PRNewswire - Techseriesinsight

December 30, 2024
PRNewswire
Security

Online Justice Launches to Help Victims Recover Lost Funds

To combat the alarming surge of online scams, Online Justice, a leading cyber intelligence firm, is now officially on the scene to help affectees reclaim their stolen funds. By addressing...

December 30, 2024
PRNewswire
Artificial Intelligence

Huawei and Moroccan Government Boost National Education Transformation through DigiSchool Project

Huawei has announced the successful completion of the DigiSchool 2024 project in Morocco, highlighting its contribution to ensuring equitable access to digital technology for all students in the Kingdom. Launched...

December 30, 2024
PRNewswire
Artificial Intelligence

Interpretation.AI – Fault Interpretation Capabilities Added

Cognitive GeoInterpretation, Inc. (“CGI”) is pleased to announce upgraded functionality related to its Interpretation.AI software (“IAI”). IAI enhances the efficiency & productivity of exploration workflows by harnessing the latest...

December 24, 2024
PRNewswire
Data Management Platform

Customer Data Platform Growth Shifts to New Markets: CDP Institute Report

The Customer Data Platform industry is shifting to new users, industries, and regions for a second wave of growth, according to the latest member survey from the Customer Data...

December 24, 2024
PRNewswire
Blockchain Technology

Bybit Champions Web3 Innovation and Strengthens Ties with Asia’s Crypto Community at Taipei Blockchain Week

Bybit, the world’s second-largest cryptocurrency exchange, debuted at the Taipei Blockchain Week Dec. 12 to 14, 2024, spotlighting the vibrant Web3 innovations on its platform alongside a dynamic roster of its strategic...

December 24, 2024
PRNewswire
Biotechnology

Ractigen Therapeutics Announces First Patient Dosed in Phase I Clinical Trial for RAG-17 in SOD1-ALS

Ractigen Therapeutics, a clinical-stage pharmaceutical company dedicated to developing RNA-based innovative therapies, today announced the successful dosing of the first patient in the Phase I clinical trial of RAG-17,...

December 24, 2024
PRNewswire
Joint Ventures

Bio-Thera Solutions Partners with Tabuk Pharmaceuticals to Commercialize BAT2206, a Stelara® (Ustekinumab) Biosimilar in Saudi Arabia

Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and a pipeline of biosimilars, today announced the company has partnered with Tabuk Pharmaceutical Manufacturing Company (a fully-owned subsidiary...

December 23, 2024
PRNewswire
Business Broadcast

TECHTRONIC INDUSTRIES JOINS THE UN GLOBAL COMPACT

Global cordless power tool, outdoor power equipment and floorcare company Techtronic Industries Co. Ltd. (“TTI” or the “Company”) (stock code: HK:0669, ADR symbol: TTNDY) today announced that it has...

December 23, 2024
PRNewswire
Analytics

New Report: What rises in the East and goes down in the West? Ambition to lead

Professionals in Western countries are less ambitious and less interested in work than their ‘Global South’ peers, a new global study by Amrop, a leading global executive search and...

December 23, 2024
PRNewswire
Biotechnology

Aptamer developed by HKBU for treating rare bone disease ‘X-linked hypophosphatemia’ receives Orphan Drug Designation and Rare Pediatric Disease Designation by U.S. FDA

A research led by Hong Kong Baptist University (HKBU) and the Shanghai Sixth People’s Hospital Affiliated to School of Medicine at Shanghai Jiao Tong University (Shanghai Sixth People’s Hospital) has discovered...